SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-043318
Filing Date
2018-08-09
Accepted
2018-08-09 16:31:38
Documents
86
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv500186_10q.htm 10-Q 780991
2 EXHIBIT 31.1 tv500186_ex31-1.htm EX-31.1 11068
3 EXHIBIT 31.2 tv500186_ex31-2.htm EX-31.2 11078
4 EXHIBIT 32.1 tv500186_ex32-1.htm EX-32.1 4420
5 EXHIBIT 32.2 tv500186_ex32-2.htm EX-32.2 4587
  Complete submission text file 0001144204-18-043318.txt   8845880

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eltp-20180630.xml EX-101.INS 2831137
7 XBRL TAXONOMY EXTENSION SCHEMA eltp-20180630.xsd EX-101.SCH 60165
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eltp-20180630_cal.xml EX-101.CAL 32916
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eltp-20180630_def.xml EX-101.DEF 369960
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltp-20180630_lab.xml EX-101.LAB 384046
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltp-20180630_pre.xml EX-101.PRE 425708
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-15697 | Film No.: 181005532
SIC: 2834 Pharmaceutical Preparations